Release Date: 10/10/12 10:11 Summary: AGL PRESENTATION TO APPEA CONFERENCE BRISBANE Price Sensitive: No Download Document 779.55KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status